OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Cardiology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Vascular regenerative cells in cardiometabolic disease	76
Pemafibrate and other triglyceride-lowering therapies to reduce risk of cardiovascular and metabolic disease	34
Assessment and management of neonates with unrepaired congenital heart disease	28
Persistent inflammatory residual risk despite aggressive cholesterol-lowering therapy: what is next?	19
Editorial introductions	17
Editorial: from albuminuria to uric acid – emerging risk factors beyond lipids	16
Temporary mechanical circulatory support devices: updates from recent studies	16
Advances in device-based therapies for cardiorenal syndrome	15
Device therapy for heart failure management	14
Genetics of sudden cardiac death	13
REVIVED BCIS-2: update and key learnings	13
Role of medical management of cardiogenic shock in the era of mechanical circulatory support	13
Cardiac phenotypes in LMNA mutations	12
Editorial introductions	12
Editorial introductions	12
Donation after circulatory determination of death in heart transplant: impact on current and future allocation policy	11
Epigenetic remodeling in heart failure with preserved ejection fraction	11
Cryoballoon atrial fibrillation ablation experience in Japan	10
Imaging of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy	10
Challenges in diagnosis and management of coarctation of the aorta	10
Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care	10
Team-based strategies to prevent heart failure	10
Cardiac selectivity in pulsed field ablation	10
Clinical considerations and pathophysiological associations among obesity, weight loss, heart failure, and hypertension	10
Coronary artery disease in patients with cancer: challenges and opportunities for improvement	10

Recent clinical trials in atrial fibrillation	10
Editorial introductions	9
Coronary artery bypass grafting in low ejection fraction: state of the art	9
Multimodality cardiovascular imaging in hypertension	9
Radiofrequency lesion formation prediction with contact force versus local impedance	9
The impact of transcatheter edge-to-edge repair on mitral valve annular geometry	9
Wellness and burnout in cardiac surgery: not black and white	9
Near infrared spectroscopy in the pediatric cardiac intensive care unit: accurately interpreting the data	8
Integration of palliative care across the spectrum of heart failure care and therapies: considerations, contemporary data, and challenges	8
The mitral valve in hypertrophic cardiomyopathy	8
Bicuspid aortic valve associated aortopathy: 2022 guideline update	8
Weight loss and atrial fibrillation: a review	8
Management of hypertension in heart transplant recipients: an ongoing conundrum	8
Contemporary management of infective native aortic aneurysms	8
Sleep apnea and cardiovascular risk	8
Electrographic flow mapping of atrial fibrillation	7
Albuminuria and cardiorenal risk	7
Is the world ready for the STICH 3.0 trial?	7
Improving outcomes after low-risk coronary artery bypass grafting: understanding phase of care mortality analysis, failure to rescue and recent perioperative recommendations	7
Expanding revascularization trials to women and underserved minorities and shifting to patient-centered outcomes: RECHARGE trials program	7
Less invasive multivessel coronary artery bypass grafting: now is the time	7
Update on the molecular landscape of thoracic aortic aneurysmal disease	6
The pleiotropic cardiovascular effects of sodium-glucose cotransporter-2 inhibitors	6
Current and future transcatheter aortic valve replacement valves	6
Catheter-based therapies in acute and chronic pulmonary embolism	6
Factor XI inhibitors: what should clinicians know	6
Bad behavior in healthcare: an insidious threat to patients, staff, and organizations	6
Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?	6
Editorial introductions	6
New wrinkles in hypertension management 2022	6
Promoting gender diversity and ergonomic equity in the cardiac surgery operating room	6
Epidemiology and risk factors for stroke in young individuals: implications for prevention	6
When should the tricuspid valve be repaired during mitral valve repair?	6
A tale of two balloons: technical and procedural difference between cryoballoon systems	5
Destination LVAD therapy in the current era of the heart transplant allocation system	5
Artificial sweeteners and cardiovascular risk	5
Improving diversity in cardiac surgery clinical trials with ROMA:Women as an exemplar	5
Long noncoding RNAs in cardiovascular disease	5
Clinical trials of cell therapy for heart failure: recent results warrant continued research	5
Disparity issues in coronary artery surgery	5
Robotic mitral valve surgery: evolving history, techniques, and training paths	5
Electronic health strategies to improve medication adherence in patients with cardiometabolic disease: current status and future directions	5
Coronary artery calcium and sudden cardiac death: current evidence and future directions	5
Coronary plaque features on CTA can identify patients at increased risk of cardiovascular events	5
How to deal with nonsevere stenoses in coronary artery bypass grafting – a critical perspective on competitive flow and surgical precision	5
Editorial introductions	5
Peripheral arterial disease and hypertension	5
Influenza vaccination in mitigating vascular events and risk	4
Management of pregnancy in left ventricular assist device and heart transplant recipients: a concise review	4
High lipoprotein(a) is a risk factor for peripheral artery disease, abdominal aortic aneurysms, and major adverse limb events	4

The management of new-onset atrial fibrillation in critical illness: an update on current therapeutic options	4
Double outlet right ventricle – the 50% rule has always been about the conus	4
Building resilient heart center teams	4
Optimal medical therapy after coronary artery bypass grafting: a primer for surgeons	4
Mitral valve surgery after failed transcatheter edge-to-edge repair: a review and word of caution	4
Editorial introductions	4
Chronic thromboembolic pulmonary hypertension anno 2021	4
Arrhythmogenic right ventricular cardiomyopathy in the pediatric population	4
Statin-Associated muscle symptoms and vitamin D supplementation	4
Editorial: the year in lipids and emerging risk factors	4
Left main revascularization guidelines: navigating the data	4
Clinical impact of genetic testing for lipid disorders	4
Editorial: Current opinion on controversial issues in coronary artery bypass surgery	4
Editorial introductions	4
Ischemic mitral regurgitation: when should one intervene?	4
Brugada syndrome – minimizing overdiagnosis and over treatment in children	4
Pharmacogenetics of cardiovascular drugs	4